Maternal-Fetal Medicine · Prenatal Counseling

NIPT Positive for
Monosomy X

Clinical Discussion & Patient Counseling
Turner Syndrome (45,X)

Screening Result Diagnostic Pathway Counseling Framework
Understanding the Result

NIPT is a Screening Test

29.4%
Positive Predictive Value
for Turner Syndrome (45,X)
42.9%
Overall PPV for Sex
Chromosome Aneuploidies
59%
Rate of Confined
Placental Mosaicism

cfDNA originates from the placenta, not directly from the fetus

Interpreting the Result

Why False Positives Occur

🧬
Confined Placental Mosaicism (CPM)
Abnormal cells present in the placenta but not in the fetus.

Accounts for 59% of discordant Monosomy X NIPT results.
👩
Maternal Mosaicism
Unrecognized maternal Turner mosaicism sheds 45,X cfDNA into maternal circulation.

Mimics a fetal anomaly on NIPT.

A positive NIPT result requires confirmation — it does not establish a diagnosis.

Obstetric Management

Mandatory Ultrasound Evaluation

🔬
Detailed Anatomy Scan
Comprehensive fetal survey
❤️
Fetal Echocardiogram
Structural cardiac defects
📏
Nuchal Translucency
Increased NT assessment
💧
Fetal Hydrops
Fluid accumulation survey
A normal ultrasound decreases the post-test probability of true fetal 45,X and raises suspicion for placental or maternal mosaicism.
Diagnostic Pathway

Diagnostic Testing Strategy

Modality Timing Target Tissue Clinical Utility Status
Amniocentesis ≥ 15 weeks Fetal amniocytes Definitive diagnosis; bypasses placental discordance Preferred
CVS 10 – 13 weeks Placental trophoblast High risk of diagnostic error due to CPM; concordant CVS + NIPT most likely reflects CPM Use Caution
Maternal Karyotype Any gestational age Maternal blood Indicated when NIPT, ultrasound, and fetal testing are discordant As Indicated
Maternal Counseling

Prognosis & Clinical Features

📊
Prevalence
1 in 2,000 – 2,500 live births.

Confirmed 45,X carries a high rate of spontaneous first-trimester loss.
🧠
Neurocognitive Profile
Intellectual capacity is typically normal.

Specific neurocognitive challenges (visuospatial, executive function) may arise.
🌱
Postnatal Features
Short stature · Ovarian dysgenesis
Delayed or absent puberty · Infertility

Hormone replacement therapy is available and effective.
❤️‍🩹
Lifelong Morbidity
Increased risk of cardiovascular anomalies, autoimmune disease, and metabolic dysfunction across the lifespan.
Clinical Action Plan

Moving Forward Together

1
Targeted Ultrasound
Anatomy scan & fetal echocardiogram scheduled promptly
2
Genetic Counseling
Specialized prenatal genetic counselor referral
3
Amniocentesis
Definitive diagnostic testing at ≥15 weeks
4
Informed Decision
Results reviewed; pregnancy management plan established with your team
25% of patients with confirmed fetal sex chromosome aneuploidy choose to continue their pregnancies following specialized genetic counseling. Your team supports every decision.
← OpenMFM Library